Description
Semax is a synthetic peptide analogue derived from the adrenocorticotropic hormone (ACTH) fragment, specifically modified for research purposes. In laboratory contexts, Semax allows researchers to study receptor interactions, peptide signalling, and molecular effects without the complexities of broader systemic influences.
Research Background
Research has focused on Semax’s interaction with BDNF pathways, its potential neuroprotective effects following ischaemic events, and its influence on dopaminergic and serotonergic systems in animal models. It is frequently studied alongside Selank as part of a cognitive and neurological research protocol.
Specifications:
- Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
- Purity: ≥99% (HPLC verified)
- Format: Lyophilised powder
- Quantity: 5mg per vial
Important Notice
This product is supplied strictly for in vitro laboratory research purposes. It is not intended for use in humans or animals. It has not been evaluated by the MHRA, the FDA, or any other regulatory authority for safety or efficacy in any application. This product must not be used as a medicine, food supplement, or cosmetic ingredient. Researchers are responsible for ensuring compliance with all applicable local regulations governing the use of research compounds.
For laboratory research use only. Not for human or veterinary consumption.
Reviews
There are no reviews yet.